Berkeley Catalyst — Full Portfolio
27 tracked investments · listed companies and verified rows first
Menlo Park, US
Board seatLaura Smoliar· per SEC Form D · $5.6M raise · filed Nov 2017
Newark, US
OMAR YAGHI(Executive Officer, Director)Frank Ramirez(Executive Officer, Director)WILLIAM GALLO(Executive Officer, Director)
BoardSudhir Joshi(Director)Michael C. Phillips(Director)Christian Thirion(Director)
Board seatLaura Smoliar· per SEC Form D · $8M raise · filed Aug 2019
Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits.
BiotechDeep TechHealthtechKensington, US
Joseph Bondy-Denomy(Director)David Rabuka(Executive Officer, Director, Promoter)Karen Boezi(Director)
Co-investorsDolby Family Ventures
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Kalyan Handique(Executive Officer, Director)John Younger(Executive Officer, Director)James Militello(Executive Officer)
BoardJeffrey S. Williams(Director)Paul D'Amato(Director)Dan Kidle(Director)in
Co-investorsArboretum VenturesBeringeaBlueStone Venture PartnerseLab VenturesID VenturesInvest Michigan+5 more
Co-investorsPrefix CapitalTrousdale Ventures
Amplicore develops injectable regenerative therapeutics for degenerative musculoskeletal disorders, including joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears.
BiotechHealthtechMedical Devices
Avvio Medical develops Microbubble SonoLithotripsy, a minimally invasive outpatient procedure that uses low-intensity ultrasound to break down ureteral stones without requiring general anesthesia or stents.
Deep TechHealthtechMedical DevicesSan Francisco, US
Co-investorsBaruch Future VenturesMission Bay CapitalMission Biocapital
Arima Genomics is a cancer diagnostics company using 3D genome science and Hi-C sequencing to detect cancer-driving genomic alterations that conventional DNA and RNA profiling methods miss.
BiotechDigital HealthHealthtechMedical Devices
Sid Selvaraj(Founder & Chief Operating Officer)Tom Willis(Chief Executive Officer)Anthony Schmitt(Senior Vice President, Science)Erin Davis(Vice President, Marketing)
Co-investorsIllumina Ventures
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Matthew P. Jacobson(Co-founder)Scott R. Lokey(Director)Matthew Jacobson(Director)David J. Earp(President & CEO)Paul Park(Executive Officer)
BoardThilo Schroeder(Director)in
Co-investorsLifeforce CapitalMission Bay CapitalMission BiocapitalNextech InvestPandect BioventuresThe Column Group+1 more
Enables people to live more deliberate lives through data-driven insights
BiotechEmeryville, US
Jay Keasling(Executive Officer, Director)Darren Platt(Executive Officer)Jeff Ubersax(Executive Officer)William Haseltine(Director)Haorui Zhang(Director)
Co-investorsWinklevoss CapitalHorizons Ventures
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.
BiotechDeep TechSan Francisco, US
Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)
BoardAndrew Cain McClary(Director)Drew Lanza(Director)
Co-investorsBlue Bear VenturesKdT Ventures
Frontier Medicines is a drug discovery company that combines chemoproteomics and AI to develop covalent small-molecule therapeutics against difficult-to-drug protein targets.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Chris Varma, Ph.D.(Executive Officer, Director)Chris Varma(Co-founder, Chairman and CEO)Jim Winkler(Executive Officer)Johannes Hermann, Ph.D.(Executive Officer)Kevin Webster(Executive Officer)Gregory Chow(Executive Officer)
Co-investorsDCVC (Data Collective)Droia VenturesMPM BioImpactRA CapitalDCVC BioDeerfield Management Company
Inhalon Biopharma is a clinical-stage biotechnology company developing inhaled "muco-trapping" antibody treatments for acute respiratory infections, including RSV, influenza, human metapneumovirus, and SARS-CoV-2.
BiotechHealthtechCarrboro, US
Samuel Lai(Executive Officer, Director)John B. Whelan(Executive Officer, Director)Winnie Wan(Director)Sam Lai(Founder)John Whelan(Chief Executive Officer)
Co-investorsFlucas Ventures
Invenio develops rapid on-site tissue imaging systems combined with AI to improve cancer patient care.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Clara, US
Jay Trautman(President & CEO, Co-Founder)Chris Freudiger(Chief Technology Officer, Co-Founder)Christian Freudiger(Director)Xiaoliang Xie(Director)
BoardDoug Crawford(Director)in
Co-investorsMission Bay CapitalMission Biocapital
LogicInk develops wearable biochemical sensors that detect environmental and personal health signals—such as UV exposure, air quality, and microbiome changes—to provide real-time wellness feedback.
BiotechConsumerHardwareHealthtechWellness & FitnessSan Francisco, US
Carlos Olguin(Founder & CEO)inHendrik Dietz(Scientific Co-Founder)in
Co-investorsKrillion VenturesAtypical VenturesVillage GlobalMission Biocapital
Madorra develops a nonhormonal, noninvasive medical device to treat vaginal dryness and vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors.
FemTechHealthtechMedical DevicesPortland, US
Holly Rockweiler
Co-investorsPortfoliaPortland Seed FundSocial StartsElevate CapitalOneVentures
Nelumbo develops PFAS-free surface coatings for anti-ice and water repellency, including IceNein for heat exchangers in refrigeration and HVAC systems to reduce ice formation and improve energy efficiency, and Mineral for durable water-repellent textiles.
CleantechDeep TechNew Materials
Co-investorsPrime Movers LabSafar Partners1517
Newomics develops the UniESI system, a multiomics front-end platform using its M3 emitter and MEA chip "multispray" technologies for microflow and nanoflow LC-MS.
BiotechDeep TechHardwareBerkeley, US
Pan Mao(Director)Daojing Wang(Executive Officer, Director)Patrick Scannon(Director)
Fremont, US
Shrinivas Shetty(Executive Officer, Director)David Sungsu You(Director)Rami El Assal(Director)Kishore Karkera(Executive Officer)Art Zafiropoulo(Director)
BiotechResearch Triangle Park, US
Rachelle Galvin(Executive Officer, Director)Christopher Belnap(Executive Officer, Director)Greg Werner(Executive Officer, Director)
BoardDrew Lanza(Director)inEric Eason(Director)John Peryam(Director)in
Co-investorsFulcrum Global Capital
SwineTech builds technology for pork producers, including SmartGuard, a voice-recognition and wearable system that reduces piglet crushing, and PigFlow, a workflow and execution-management platform for coordinating daily work across pork production operations.
AgTechAI & Machine LearningSaaSSolon, US
Abraham Espinoza(Co-founder)Matthew Rooda(Co-founder & CEO)John Rourke(Co-founder)
BoardGlenn Argenbright(Director)Jan Bouten(Director)inRussell Gilliam(Director)
Co-investorsAg Ventures AllianceInnova Memphis, Inc.ISA VenturesCultivation Capital
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)Gregory D. Kunst(Chief Executive Officer)Carole H Bellis(Executive Officer)Kevin E Healy(Director)Jackson M Wesley(Executive Officer, Director)
BoardDrew Lanza(Director)in
Co-investorsAngel Physicians FundExSight VenturesFirst Spark Ventures, LlcPandect Bioventures
4D Molecular Therapeutics develops genetic medicines using a directed-evolution vector platform to create customized AAV vectors optimized for specific diseases.
BiotechHealthtech
Co-investorsAmzak HealthBOLD LongevityPfizer Venture Investments
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.